Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 3/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | ACE | P12821 | 4/20 | 0.57 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | CPA1 | P15085 | 2/20 | 0.54 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.53 |
| ▸ | FPR2 | P25090 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3505515 | 0.86 | MME (0.63) | MMENPSR1ACENAALAD2PTPN1 | |
| SCHEMBL5791502 | 0.86 | MME (0.63) | MMENPSR1ACENAALAD2PTPN1 | |
| SCHEMBL10013202 | 0.86 | MME (0.63) | MMENPSR1ACENAALAD2PTPN1 | |
| SCHEMBL30231743 | 0.85 | MME (0.55) | MMENPSR1ACENAALAD2PTPN1 | |
| SCHEMBL528464 | 0.84 | ACE (0.76) | MMEACEPTPN1L3MBTL1CA2 | |
| SCHEMBL111236 | 0.84 | ACE (0.76) | MMEACEPTPN1L3MBTL1CA2 | |
| SCHEMBL111235 | 0.84 | ACE (0.76) | MMEACEPTPN1L3MBTL1CA2 | |
| SCHEMBL28419446 | 0.83 | ACE (0.74) | MMEACEPTPN1L3MBTL1CA2 | |
| SCHEMBL596491 | 0.83 | MME (0.59) | MMENPSR1ACENAALAD2L3MBTL1 | |
| SCHEMBL28419447 | 0.83 | ACE (0.74) | MMEACEPTPN1L3MBTL1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2183201-B1 | PROCESS FOR THE RESOLUTION OF ZOPICLONE AND INTERMEDIATE COMPOUNDS | ESTEVE QUIMICA SA (ES) | 2012-03-28 | — | — | EP | disclosed |